Akso Health Income Statement (2017-2026) | AHG

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.34M122.81M0.55M0.02M0.10M3.03M0.05M
Cost of Revenue (Quarter)
3.21M2.05M1.36M2.18M2.25M1.61M2.22M
Gross Profit (Quarter)
-2.87M120.75M-0.82M-2.15M-2.15M1.42M-2.17M
Operating items
Research & Development (Quarter)
5.48M3.50M11.67M11.75M7.18M-29.42M9.27M
Selling, General & Administrative (Quarter)
2.27M1.70M2.31M2.24M3.25M-4.67M2.59M
Other Operating Expenses (Quarter)
3.93M3.16M1.58M7.09M2.63M-4.71M2.97M
Operating Expenses (Quarter)
11.69M8.35M15.56M21.07M13.05M-38.80M14.83M
Operating Income (Quarter)
31.62M20.44M36.09M-17.45M-11.14M-1.43M-10.29M
EBIT (Quarter)
31.62M20.44M36.09M-17.45M-11.14M-1.43M-10.29M
Non-operating items
Interest & Investment Income (Quarter)
0.10M0.09M-0.20M-0.04M-0.37M-0.17M
Other Non Operating Income (Quarter)
0.25M1.11M0.48M0.61M1.18M1.08M0.85M
Non Operating Income (Quarter)
0.24M0.47M0.61M1.17M0.84M
Net income details
EBT (Quarter)
31.86M19.43M36.56M16.85M-9.97M-16.55M-9.44M
Tax Provisions (Quarter)
4.96M2.38M6.88M0.55M-0.38M-6.20M0.96M
Profit After Tax (Quarter)
26.91M17.05M29.68M-17.40M-9.59M-10.30M-10.40M
Income from Non-Controlling Interests (Quarter)
0.03M
Income from Continuing Operations (Quarter)
26.91M17.05M29.68M16.29M-9.59M-10.35M-10.40M
Income from Discontinued Operations (Quarter)
4.96M2.38M-0.38M-5.19M
Consolidated Net Income (Quarter)
31.86M19.43M29.68M16.29M-9.97M-15.53M-10.40M
Income towards Parent Company (Quarter)
31.86M19.43M29.68M16.29M-9.97M-15.53M-10.40M
Net Income towards Common Stockholders (Quarter)
26.87M18.18M29.89M17.40M-9.59M3.92M-10.40M
Additional items
EPS (Basic) (Quarter)
1.751.211.871.07-0.596.36-0.64
EPS (Diluted) (Quarter)
1.561.141.690.97-0.540.22-0.64
Shares Outstanding (Quarter)
15.38M14.99M16.00M16.24M16.31M0.62M16.27M16.25M48.91M48.84M50.68M59.61M68.60M68.60M68.60M141.52M699.05M855.29M1,767.30M2,168.12M
Shares Outstanding (Diluted) (Quarter)
17.18M15.89M17.67M17.92M17.72M17.64M16.27M16.25M16.25M48.84M50.68M59.61M68.60M68.60M68.60M141.52M699.05M855.29M1,767.30M2,168.12M
Shares Outstanding (Entity) (Quarter)
15.38M14.99M16.00M16.24M16.31M0.62M16.27M16.25M16.30M16.28M16.89M19.87M22.87M22.87M22.87M47.17M233.02M285.10M1,767.30M2,168.12M
EBITDA (Quarter)
31.62M20.44M36.09M-17.45M-11.14M-1.43M-10.29M
Interest Expenses (Quarter)
0.01M0.00M-0.02M-0.00M-0.00M-0.02M-0.01M2.10M0.40M3.26M0.11M0.95M0.03M
Tax Rate (Quarter)
15.56%12.26%18.82%3.28%3.77%37.48%-10.13%